openPR Logo
Press release

OTC Braces & Supports Market worth $1,286 million by 2027 - Exclusive Report by MarketsandMarkets™

10-14-2022 12:00 PM CET | Health & Medicine

Press release from: MarketsandMarkets™.

OTC Braces & Supports Market

OTC Braces & Supports Market

The OTC Braces and Supports Market is valued at an estimated USD 942 million in 2022 and is projected to reach USD 1,286 million by 2027, at a CAGR of 6.4%, according to a new report by MarketsandMarkets™. Market growth is driven by the rising technological advancements in OTC braces and supports, increasing orthopedic disorders and the growing awareness of preventive diagnosis in developing countries. Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the OTC braces and supports market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=113271585

Browse in-depth TOC on "OTC Braces and Supports Market"
137 - Tables
42 - Figures
274 - Pages

The knee braces and supports segment had the major share of the OTC braces and supports Market, by product, in 2021"

Based on product, the OTC braces and supports market is divided into knee, ankle; back, hip, & spine; foot walkers and orthoses; hand & wrist; shoulder; elbow; and facial braces and supports. Due to the numerous benefits these products offer, including medial and lateral support, reduced knee rotation, limited injury in motion, and as protection from risk of injury following surgery, the knee braces and supports segment is anticipated to have the highest growth during forecast period.

In 2021, preventive care segment accounted for the largest share in the market, by application"

Based on the application, the OTC braces and supports market is segmented into preventive care, ligament injury, osteoarthritis, compression therapy, and other applications. The preventive care segment is expected to command the largest share of the market in 2022. The large share of this segment can be attributed to increasing public participation in sports-related activities and rising off-the-shelf usage of bracing products for preventive care & ambulatory procedures.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=113271585

In 2021, pharmacies and retailers segment accounted for the largest share in the market, by distribution channel"

Based on the distribution channel, the OTC braces and supports market is classified into pharmacies & retailers, e-commerce platforms, orthopedic clinics and hospitals. Pharmacies and retailers are expected to be the largest distribution channel segment in the OTC braces and supports market. The growth of this market segment is majorly driven by the wide availability of orthopedic bracing products through retailers & pharmacies, rising adoption of off-the-shelf products for sprain & ligament injuries in major countries (due to easy access), and the growing public awareness about the clinical benefits of orthopedic braces in preventive care.

"North America accounted for the largest share of the otc braces and supports market "

The global otc braces and supports market is segmented into five major regions namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America held the biggest market share of the OTC braces and supports market in 2021. Market growth is attributed to the development and commercialization of novel orthopedic braces & support products, favorable reimbursements & insurance coverage for major orthopedic bracing procedures, supportive government regulations for product commercialization, and significant sports participation.

The major players operating in this market are 3M (US), DJO Global (US), Essity (Sweden), Zimmer Biomet Holdings, Inc (US), Ottobock Healthcare (Germany), Össur HF (Iceland), medi GmbH (Germany), DeRoyal Industries Inc (US), Bauerfeind AG (Germany), Bird & Cronin (US), Breg Inc. (US), Thuasne (France), TruLife Group (Ireland), Alcare (Japan), Prim SA (Spain), and Foundation Wellness (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=113271585

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Braces & Supports Market worth $1,286 million by 2027 - Exclusive Report by MarketsandMarkets™ here

News-ID: 2767369 • Views:

More Releases from MarketsandMarkets™.

Bone Growth Stimulator Market worth $1.8 billion by 2027 - Leading Key Players are Orthofix Medical Inc. (US), Enovis (DJO Finance, LLC) (US), ZimVie (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US)
Bone Growth Stimulator Market worth $1.8 billion by 2027 - Leading Key Players a …
- Bone Growth Stimulator Market is projected to grow from USD 1.4 billion in 2022 to USD 1.8 billion by 2027, at a CAGR of 5.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth of the global bone growth stimulators market can be attributed to factors such as increasing research activities for the development of novel bone growth stimulators devices, growing demand for bone growth
Protein Expression Market worth $5.4 billion by 2027 - Exclusive Report by MarketsandMarkets™
Protein Expression Market worth $5.4 billion by 2027 - Exclusive Report by Marke …
Protein Expression Market is projected to grow from USD 2.9 billion in 2022 to USD 5.4 billion by 2027, at a CAGR of 13.3% from 2022 to 2027, according to a study published by MarketsandMarkets™. The Factors such as the increasing incidence of chronic diseases, increasing research activities on recombinant-based protein expression, growth in the life sciences and biopharmaceutical industries, as well as the availability of funding for protein-based research.
Artificial Intelligence (AI) in Medical Diagnostics Market worth $5.5 billion by 2027 - Exclusive Report by MarketsandMarkets™
Artificial Intelligence (AI) in Medical Diagnostics Market worth $5.5 billion by …
Artificial Intelligence (AI) in Medical Diagnostics Market is projected to grow from USD 1.0 billion in 2022 to USD 5.5 billion by 2027, at a CAGR of 39.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The application of AI in medical diagnostics is growing at a fast pace owing to factors such as growing government initiatives to drive the adoption of AI-based technologies, rise in adoption
Leukapheresis Market is projected to reach $98 million by 2027 Globally, at a CAGR of 8.5% - Exclusive Report by MarketsandMarkets™
Leukapheresis Market is projected to reach $98 million by 2027 Globally, at a CA …
Leukapheresis Market is projected to grow from USD 65 million in 2022 to USD 98 million by 2027, at a CAGR of 8.5% from 2022 to 2027, according to a new report by MarketsandMarkets™. While the high cost of therapeutic leukapheresis and leukopaks is expected to restrain the global Leukapheresis market during the forecast period, the increasing incidence and prevalence of leukemia, and the high demand for leukopaks in clinical

All 5 Releases


More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current